Campaign to prioritise disabled children as Pfizer vaccine approved for use in 12- to 15-year-olds
Friday, June 4, 2021
The Pfizer-Biontech Covid-19 vaccine has been approved for use for 12- to 15-year-olds sparking calls to prioritise diasbled children if it is rolled-out.
Register now to continue reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
- Free access to 4 subscriber-only articles per month
- Unlimited access to news and opinion
- Email newsletter providing advice and guidance across the sector